23-Feb-18, Deal Street Asia
Hong Kong-listed medical device manufacturer MicroPort Scientific Corporation and Chinese PE firm Yunfeng Capital will acquire the cardiac rhythm management business of US-listed medical technology company LinaNova for USD190 mn in cash.
%20Deal%20Street%20Asia.jpg "MicroPort partners Chinas Yunfeng to buy LivaNova (c) Deal Street Asia")
Image: Deal Street Asia
MicroPort will contribute 75 per cent, while Yunfeng Capital will provide the remaining 25 per cent.
The companies will acquire a business franchise that develops, manufactures and markets products for the diagnosis, treatment and management of heart rhythm disorders and heart failures.